PARSIPPANY, N.J., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (Nasdaq:PCRX) today announced that a replay of the company's fourth quarter and full-year 2013 financial results conference call, which took place today on Tuesday, February 25, 2014, at 9 a.m. ET, can be accessed by dialing 1-855-859-2056 (domestic) or 1-404-537-3406 (international), and providing the Conference ID 16366107. The replay of the call will be available for two weeks from the date of the live call.
The live, listen-only webcast of the conference call can also be accessed by visiting the "Investors & Media" section of the company's website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the call.
Pacira Pharmaceuticals, Inc. (Nasdaq:PCRX) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com.
CONTACT: Investor Contact: Pacira Pharmaceuticals, Inc. Jessica Cho, (973) 254-3574Source:Pacira Pharmaceuticals, Inc.